YV

Yogesh Verma

Active Director Director DIN 07837282
DIN 07837282 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Yogesh Verma

Data last updated:

Yogesh Verma is a Director at Pro-Pharma Care Private Limited (since 2017). The company operates in Pharma. Pro-Pharma Care Private Limited reported revenue of ₹38.89 Cr (FY 2024).

DIN 07837282
Primary Designation Director
Industry Pharma
First Appointment 31 May 2017
Oldest Company Age 14 yrs
Largest company Pro-Pharma Care Private Limited · ₹38.89 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pro-Pharma Care Private Limited U85100UR2012PTC000458
Director31 May 20172012₹38.89 Cr (FY 2024)Active

Board colleagues of Yogesh Verma

NameDINCompanyDesignation
Subhash Rijhwani00155029Pro-Pharma Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pro-Pharma Care Private Limited
Premium access

Shareholding and investment profile for Yogesh Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Verma

Yogesh Verma currently holds 1 directorship: Pro-Pharma Care Private Limited (Director, since 31 May 2017, revenue ₹38.89 Cr (FY 2024)).

Yogesh Verma was first appointed on 31 May 2017 as Director at Pro-Pharma Care Private Limited.

The current boards of Yogesh Verma's companies include Subhash Rijhwani (Pro-Pharma Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available